Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a minor maintenance update to the page build without changing study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3, reflecting a minor version bump in the underlying platform.SummaryDifference0.1%

- Check36 days agoChange DetectedSite software revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedWebsite updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. These are administrative UI/text updates and do not alter study data or participation information.SummaryDifference0.4%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.